|
|
|
|
|
|
|
|
|
20.07.26 - 15:51
|
XFRA: 04X: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
PERSONALIS INC. DL-,001 04X US71535D1063
AB/FROM ONWARDS 20.07.2026 15:27 CET...
|
|
|
|
|
|
|
20.07.26 - 15:21
|
Tempus AI will AKTIONÄR-Tipp schlucken – 70 Prozent seit Ende Mai (Der Aktionaer)
|
|
|
Es gab bereits Gerüchte, doch nun ist es amtlich: Für die Aktionäre des Krebsgenomik-Spezialisten Personalis hat Tempus AI ein Übernahmeangebot vorgelegt. AKTIONÄR-Leser können sich auf ein ordentliches Kursplus seit der Empfehlung Ende Mai freuen. Die Aktie von Tempus AI hingegen wird in einer ersten Reaktion abgestraft und fällt zeitweise gut sieben Prozent....
|
|
|
|
|
20.07.26 - 14:57
|
XFRA: 04X: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
PERSONALIS INC. DL-,001 04X US71535D1063 BAW/UFN...
|
|
|
|
|
20.07.26 - 14:39
|
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform (Business Wire)
|
|
|
Acquisition brings together Personalis' MRD technology with Tempus' commercial scale, multimodal data and AI platform to advance cancer monitoring, deepen insights and accelerate growth
Expands Tempus' reach across the cancer care continuum and accelerates access to industry-leading technology within the rapidly emerging MRD market, a $20 billion opportunityFREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that it has entered into a definitive agreement to be acquired by Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care. The acquisition will expand Tempus capabilities in minimal residual disease (MRD) and enhance its ability to support patients from diagnosis and treatment selection, to recurrence and monitoring.
Under the terms of the agreement, Personalis shareholders will receive consideration of $16.25 per share of common stock, represent...
|
|
|
20.07.26 - 14:33
|
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform (Business Wire)
|
|
|
Acquisition brings together Personalis' MRD technology with Tempus' commercial scale, multimodal data and AI platform to advance cancer monitoring, deepen insights and accelerate growth
Expands Tempus' reach across the cancer care continuum and accelerates access to industry-leading technology within the rapidly emerging MRD market, a $20 billion opportunityCHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that it has entered into a definitive agreement to acquire Personalis, Inc. (NASDAQ: PSNL). The acquisition will expand Tempus' capabilities in minimal residual disease (MRD) and enhance its ability to support patients from diagnosis and treatment selection, to recurrence and monitoring.
Under the terms of the agreement, Personalis shareholders will receive consideration of $16.25 per share of common stock, representing a total enterprise value of $1.5 billion, net of Tempus' exist...
|
|
|
20.07.26 - 08:12
|
Paukenschlag: AKTIONÄR-Tipp Personalis im Übernahme-Visier? (Der Aktionaer)
|
|
|
Spekulationen um eine mögliche Übernahme haben die Aktie von Personalis gegen Ende der vergangenen Handelswoche angetrieben. Laut einem Medienbericht soll es mehrere mögliche Kaufinteressenten für den US-amerikanischen Krebsgenomik-Spezialisten geben, der derzeit mit etwa 1,6 Milliarden Dollar kapitalisiert wird....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
